Plasmid Derived External Quality Controls for Genetic Testing
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.Methods in molecular biology (Clifton, N.J.) (Impact Factor: 1.29). 07/2013; 1015:189-97. DOI: 10.1007/978-1-62703-435-7_12
Since the human genome has been fully sequenced, and presence of single nucleotide polymorphisms (SNPs) appeared abundant, many studies are associating SNPs with clinical response or even with disease. For some diseases or drug treatments these associations are clear, so that genetic screening for such SNPs or mutations is a standard procedure. For that reason, many different techniques have been developed for fast and easy screening for such specific SNPs/mutations. For reliable screening, the use of controls with known genotypes is indispensable. Plasmids are an ideal tool for making controls which can serve as an inexhaustible source, making new validation superfluous.In this chapter we describe how plasmid controls can be made using DNA with a heterozygous genotype, and also from DNA of which only one allele is available.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.